bbotox-depression-long island

Botox for Depression

Long Island psychiatrist Dr. Edward Fruitman, M.D. is positive that Botox helps with depression symptoms

bbotox-depression-long islandYears into his career, psychiatrist Dr. Edward Fruitman, M.D. noticed a trend: Patients who experienced depression & anxiety also felt dissatisfied with their physical appearance. More than that, he noticed that bodies reacted negatively to emotional malaise—wrinkles deepened & multiplied, creating an intractable cycle that inhibited happiness.

Anyone who has suffered even minor symptoms of depression will know how dark and low the world can feel. While everyone else seems to be smiling and living life to the full, you’re left feeling like everything is hopeless & wondering what you did in a former life to deserve it.

The most common first port of treatment contact is antidepressants, yet we all know that one size never fits all, and not everyone responds positively to medications, or even feels comfortable taking them.

Because of this, several different treatment options have been researched, and one that has proved to be perhaps the most outlandish, but also very effective, is the use of Botox cosmetic for depression.

Basically, back in the day, Charles Darwin stated the correlation between how we feel and the facial expressions we show to the world. For example, if we’re forever frowning, we’re likely to feel down; however, if we’re smiling, we will feel much better as a result.

This is where the science comes into it.
Botox is known to paralyze the facial muscles that cause wrinkles, often as a result of years of frowning as well as aging. When you’re unable to frown because of the use of Botox injections NYC, you have no alternative but to smile – so of course, if we’re to be going down the line that Darwin suggested, you will feel more positive as a result of your treatment.

Several studies have shown this, and a recent study in the Journal of Psychiatric Research showed that a massive 17 out of 33 patients who underwent Botox treatment showed a drastic improvement in their depressive symptoms. Other similar studies have yielded results in the same vein.

While Botox treatment NYC has its doubters, and still remains one of those Marmite procedures, it is increasingly popular year upon year, and the bonus is that there are no major side effects recognized, where as antidepressant medication of course carries risks, as any medication does.

This is all further weight to the argument and suggestion that Botox treatment could soon be a well recognized alternative treatment for the often severe symptoms of depression, meaning a brighter future for those who don’t particularly want to pop pills to control their condition.

Call Today! 516-295-4867

1451 Broadway, Hewlett, NY 11557

TMS treatment Long Island

TMS Can Help Treat Root Causes of Depression & Anxiety

Dr. Edward Fruitman, Medical Director of South Shore Neuropsychiatric Center offers innovative genetically based treatment options for Depression and Anxiety. At South Shore Neuropsychiatric Center we offer a simple test that gives insight into our patients’ specific genetic profile which enables Dr. Fruitman to optimize medication regimen and/or offer alternative treatment options.

Recent studies suggest that early life experiences in combination with genetic predispositions are major contributors to treatment resistant anxiety and depression.  The amygdala is a region of the brain responsible for emotion regulation while the prefrontal cortex (PFC) is responsible for emotion processing. Fear inducing cues increase amygdala activity and cause the physiological responses to anxiety. The PFC regulates the amygdala effect by inhibiting autonomic and endocrine responses to stressors. In essence, the PFC controls the extent of an emotional response. Individuals that experience heightened anxiety and depressive symptoms are shown to have an inability to control and habituate responses to stressors.  Studies suggest that genetic factors may contribute to this effect. Researchers found that in “subjects carrying a substituted methionine in the BDNF gene, fear doesn’t extinguish as readily in response to repeated nonthreatening cues; in those with a valine, it extinguishes more easily. Using neuroimaging, the authors showed that polymorphism carriers exhibited more amygdala and less PFC activity with subsequent cue presentations.”  In these individuals the PFC is dormant and individuals may not respond to psychotherapy or medication.

Transcranial Magnetic Stimulation Therapy (TMS) is a noninvasive treatment option for individuals suffering from treatment resistant anxiety and depression.  TMS stimulates the PFC using noninvasive magnetic energy, which over time provides relief to depression and anxiety symptoms. Dr. Edward Fruitman is the pioneer provider of Transcranial Magnetic Stimulation (TMS) Therapy in the Five Towns area. Dr. Fruitman has successfully treated patients suffering from anxiety and depression with TMS since 2010.


ADHD and relationships – how to manage the two side by side

When it comes to relationships, we have enough problems to deal with without factoring in other issues, such as health and behaviour.


For any couple dealing with ADHD as a part of their day to day relationship life, small problems can become increasingly difficult, depending upon the severity of the symptoms.

 So how can we stop ADHD becoming a ruining factor in relationships? And how can we learn to deal with the reality of symptom management?

The first port of call is to identify symptoms and problems, and understand how they are affecting a relationship. For instance, if one partner has the condition, and the other doesn’t, then the partner without symptoms may struggle to understand the behavior and reactions of the person suffering. This can lead to resentment and loneliness, which don’t help a relationship at the best of times.

If both partners have ADHD, then you could be looking at a communication stumbling block, and plentiful arguments and disagreements.

Understanding that this isn’t a reflection on you is important in order to accept the challenges ahead. Once you know this, you can look forward in a more positive manner.

Hyperfocus can be one of those things that affects a relationship connected with ADHD. Sufferers tend to be all or nothing in the early stages of dating, and as time moves on, and things progress, the sufferer almost seems to lose interest, or that’s how it seems to the other person anyway. In reality, this isn’t the problem at all, and it’s simply a symptom of ADHD.The key here is to work on maintaining a connection and working on intimacy, to keep both parties happy.

Another issue can be the ‘walking on egg shells’ feeling, whereby one partner can feel like they’re always doing something wrong, and arguments abound. Again, it’s important to recognise that it’s the condition doing this, and not that there is anything particularly wrong underlying. This is a common issue which rears its head in ADHD affected relationships, and one that is easily managed once recognized.

Basically ADHD matters, and it’s important to realize this fact, and not just brush it under the carpet and think it will go away. A proper assessment, treatment and management will make relationships easier to manage, and when both parties understand the challenges ahead, there’s no reason why a happy, healthy, and successful relationship can’t be maintained.

If you think ADHD affect your relationship, please Call Today (516) 792-0800 to South Shore Neuropsychiatric Center in Hewlett, Long Island for professional help.

Article written by South Shore Neuropsychiatric Center 


What are the ways to treat adult ADHD?

For anyone with diagnosed adult ADHD, or anyone who suspects they have it, the effects of this sometimes debilitating condition will be well documented. Basically, suffers from adult ADHD can’t be still for long, always on the go, and every day is a struggle to remain calm, keep order, organise daily tasks, and get where they need to be, when they need to be there.

Thankfully help is at hand at South Shore Neuropsychiatric Center in Long Island, through various means that are tailored to the specific person.

For a non-suffer, handling finances is a generally easy thing – yes it might make you cry slightly at your very low bank balance, when you would quite like a bursting rich one, but on the whole, it’s easy to manage. Take an adult ADHD sufferer, and the reality is very different. Organising and paying bills on time can be difficult, which leads to a vicious circle of not meeting financial commitments, which then makes the sufferer feel down, and depression and anxiety can set in.

This vicious circle needs to be taken into hand, gaining control, through various methods, such as counselling, medications, meditation, and small, easy to remember methods, such as preparation in the morning, arranging everything need for the day the night before, talking yourself through things – these are all ways to handle the condition, and gain control back, so it doesn’t take over a sufferer’s life.

Adult ADHD should not define a person, it is simply a condition that they happen to have, and when help is sought, methods put into place, and recognition given, nobody need live a life devoid of control and happiness.

If you feel you need help, if you’re unsure whether you have the condition and have an inkling that you may, call our helpful staff today, who will discuss your symptoms and needs, and put together a tailor-made treatment plan just for you.

Article written by South Shore Neuropsychiatric Center


Ketamine: New Depression Treatment

Ketamine treatment is offered in Long Island and Manhattan by Dr. Fruitman

Depression comes in various forms. For some, it can manifest into sensations of feeling down and hopeless, but may pass within a short space of time. For others, it may be a much longer lasting effect, requiring help in the form of anti-depressant drugs to control symptoms and recover. However, for some individuals, depression can be much more debilitating and can affect one’s quality of life drastically. For these individuals, anti-depressant drugs simply may not work. Additionally, anti-depressants are also known for taking their time to kick in, and after a while, certain sufferers may see no benefit.

This is where other treatments come into play, and can have a drastic and positive effect on day to day life and one’s overall state of mind.

Ketamine or Special K is a well-known recreational drug, however when used in the properly prescribed manner, can be hugely beneficial for depression sufferers.

A recent survey attempted to measure the effectiveness of Ketamine for depression treatment; the findings showed that this powerful substance can offer hope and positive results for many individuals who have struggled to find a treatment that works for them. Of course, like any drug, Ketamine has its side effects, and should only ever be used in a controlled manner, under the watchful eye of a medical professional.

A study by the Baylor College of Medicine in Houston, as well as the Icahn School of Medicine at Mount Sinai has shown that within a 24 hour time period, out of 73 patients with severe and major depression, a quarter noticed a temporary reduction in the severity of their depressive symptoms. That is a huge amount, and offers much hope for many individuals looking for ways to improve their overall quality of life.

Depression need not take over your life completely, and help really is at hand.

Ketamine injection treatment for depression offered by Dr. Edward Fruitman, M.D. and South Shore Neuropsychiatric Center in Hewlett Long Island New York.

Call Now: 516-295-4867 and start your journey to better yourself today!

Article written by South Shore Neuropsychiatric Center



The US Food and Drug Administration (FDA) has recently approved the first brain-wave test to help diagnose attention-deficit/hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years, the agency announced.

The device, called Neuropsychiatric EEG-Based Assessment Aid (NEBA) System, is a  noninvasive test, based on electroencephalogram (EEG) technology. The system computes the ratio of theta and beta brain waves in 15 to 20 minutes, which can be used to help diagnose/or reverse diagnose ADD/ADHD in children and adolescents. Children and adolescents with ADHD have a higher theta-beta ratio than those who do not have the disorder.

Together with a complete medical and psychological workup, the NEBA System can help confirm a diagnosis of ADHD or a decision to focus further testing on ADHD or other conditions with similar symptoms, according to the FDA.

“The NEBA System along with other clinical information may help healthcare providers more accurately determine if ADHD is the cause of a behavioral problem,” Christy Foreman, director of the Office of Device Evaluation at the FDA’s Center for Devices and Radiological Health, said in a news release.

The agency based its decision to approve the NEBA System in part on a clinical study of 275 children and adolescents with attention or behavioral issues. Clinicians evaluated all of them using the new brain-wave test along with standard diagnostic protocols and physical exams. An independent panel of ADHD experts reviewed the findings to determine whether each patient satisfied the criteria for ADHD or another condition. The study showed that adding the brain-wave test to a clinical assessment helped clinicians make a more accurate ADHD diagnosis than if they had performed only the clinical assessment.

The NEBA System is made by NEBA Health, in Augusta, Georgia.

The NEBA System is now available at South Shore Neuropsychiatric Center in Hewlett, NY. Under the supervision of Medical Director, Edward Fruitman, MD, children and adolescents can be tested and the risk of ADD/ADHD misdiagnosis will be decreased exponentially. For more information call the office of Dr. Edward Fruitman (516)295-4867.


Behavioral Healthcare/ December 4, 2013

By Alison Knopf

Transcranial Magnetic Stimulation (TMS) may be the best way to help patients with treatment-resistant major depression (TRMD) – people who have tried antidepressants at least once for the appropriate amount of time on the appropriate dose, according to Pete Mumma, Administrative Director of the Behavioral Health Service Line in the Department of Psychiatry at Lancaster General Health in Lancaster, Pennsylvania. But that doesn’t mean it’s easy to “sell” the TMS device to financial people in your institution.

Here’s how Mumma did it: 9.1 percent of the population has depression, and .05 percent has TRMD. These people are “superutilizers,” who consume 18 percent of a health system’s uncompensated or undercompensated spending. “It’s unsustainable,” he said. “We expect people who have extreme needs to be treated in pathway models that don’t meet their needs – what will we do with these patients, not just from a mental health perspective, but from a total medical perspective?”

For example, an individual with TRMD who also has cardiac disease or cancer is going to be very complicated to treat. “Any medical provider who is helping patients with TRMD is going to bump up against some or all of their issues,” said Mumma. Symptoms such as lack of energy, lack of concentration, and sleep problems create further distractions for the patient, he said. The recommendations of the cardiologist or oncologist won’t go as far as they would if the patient didn’t have depression.

The impact of mental health problems on physical treatment is more relevant now than it was in the past because of the way health systems are being reimbursed, said Mumma, citing in particular the penalty for readmissions within 30 days. If a patient fails cardiac treatment – perhaps because he didn’t exercise, something that is notably difficult for people with depression – and needs to be readmitted, that’s a ding to the hospital’s bottom line. “So cardiologists and every other doctor wants to make sure they eliminate barriers to good outcomes,” he said. Mental problems that make it difficult to follow through with physician recommendations are suddenly seen as very important – a good thing for both patients and the health care system.

“We can spend a little money up front to treat the depression, and the patient’s cardiac care goes farther, faster,” said Mumma.

The treatment

Typically, patients start with a daily course of treatment, which takes about 37 minutes. This would go on for four to six weeks. The treatment is painless and requires no sedation. Once the initial course is done, some patients may come back for a maintenance treatment. The TMS doctor will determine the exact treatment protocol and any maintenance needed.


The first line of treatment for depression is medication, but people with TRMD are patients for whom medication isn’t working. On the system side, the clinical benefit is important, but on the patient side, it’s crucial. “The tragic thing is these patients aren’t getting better,” said Mumma of TRMD.

Doing depression care differently – what Mumma is suggesting is avoiding the “shotgun approach” that most depression patients who have tried one medication after another have experienced. At Lancaster, before selecting a medication, the psychiatry department does “pharmacogenetic” testing via a cheek swab to at least narrow down the type of medication to try in the first place. “But many patients get agent after agent, and have had no other options over their lifetime.” Now, at least patients who have failed one course of medication with an appropriate dose and duration have another option.

“Through medications, we’re trying to light up some parts of the brain and quiet others,” said Mumma. That’s the same thing that TMS does – the magnet near the head “reaches deep into the amygdala, which scientists think is responsible for mood,” he said. “Instead of washing the brain with chemicals, this seems to isolate the problem.” Many patients continue to take medications while getting TMS but find they can reduce their medications over time, he added.

Another issue is the cost of medications. Abilify, the medication used for treatment-resistant major depression, is very expensive, said Mumma. “The health plan might be paying more than $1,000 per month” for Abilify, he said. “Add to that the costs of Celexa or other medications, plus the medication management.”

Tracking medical costs

Mumma also has scrutinized the literature, finding that one study showed that the most costly expense to employers was depression, at a cost of more than $350,000 per thousand employees. That isn’t only medical costs, of course, but aggregated costs of medical treatment, pharmacy, absenteeism, and “presenteeism” – in which employees are still at work but unable to function. “If we were to do depression care differently, that’s a huge savings,” said Mumma.

Patients paying

In clinical trials, suicidality was four times higher in the placebo group than the TMS group, said Mumma. (In the clinical trials, TMS was compared to sham TMS, not compared to medication.)

Major depression is a devastating disease for people who don’t get better, and 40 percent of the patients experience remission, said Mumma, who is not compensated by Neuronetics.

The big question is whether TMS is going to be as effective as electroconvulsive therapy (ECT), said Mumma. Clearly TMS is much more appealing to patients. “ECT is scary as hell, and it has ugly side effects like memory loss,” he said. ECT is effective, but many studies are showing comparable results for people with TMS, said Mumma.

“Nobody’s using the word, ‘cure,’” said Mumma. But TMS is different from medications, he said. TMS is non-medication based treatment, so there are no drug-drug interactions. “It’s difficult to get off of antidepressants once you get on, and antidepressants are basically a band-aid for a problem – just symptom improvement, not managing the illness.”  TMS does allow patients to return to functionality with fewer side effects than medication, said Mumma.